Galapagos NV
GLPG
#5194
Rank
NZ$3.12 B
Marketcap
NZ$46.59
Share price
0.00%
Change (1 day)
-14.10%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2026 (TTM): NZ$0.96 Billion

According to Galapagos NV's latest financial reports the company's current earnings are NZ$1.22 Billion. In 2025 the company made an earning of NZ$0.61 Billion, an increase over its 2024 earnings that were of -NZ$9.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.96 B56.33%
2025 NZ$0.61 B-6464.81%
2024 -NZ$9.71 Million-82.77%
2023 -NZ$56.36 Million-85.59%
2022 -NZ$0.4 Billion60.71%
2021 -NZ$0.25 Billion-60.08%
2020 -NZ$0.61 Billion-331.44%
2019 NZ$0.26 B-523.76%
2018 -NZ$62.18 Million-72.34%
2017 -NZ$0.23 Billion-329.59%
2016 NZ$97.91 M-144.3%
2015 -NZ$0.23 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.64 B 4,596.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.67 B 1,371.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.03 B 980.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.86 B 1,284.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$22.09 B 2,277.78%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$24.63 B 2,551.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$16.82 B 1,709.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
NZ$0.22 B-75.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.81 B 310.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel